3.8 Review

Biliary Mucosal Barrier and Microbiome

期刊

VISZERALMEDIZIN
卷 31, 期 3, 页码 156-161

出版社

KARGER
DOI: 10.1159/000431071

关键词

PBC; Primary biliary cirrhosis; PSC; Primary sclerosing cholangitis; Cholecystolithiasis; Gallstones; Bile acids; Microbiome; Microbiota

类别

资金

  1. German Research Foundation (DFG) [SE 1122/1, SFB985/C3, SFB-TRR57/P06]
  2. European Union's Seventh Framework Programme (FP7/2007-2013)
  3. START program of the Faculty of Medicine, RWTH Aachen, Germany (START 25/11) [305564]
  4. German Cancer Aid (Deutsche Krebshilfe) [110043]

向作者/读者索取更多资源

Background: The biliary system is in continuous contact with the complex microbiota of the intestine. Microbial products have recently been proposed as potential triggers for biliary diseases. Methods: The aim of this review is to provide a summary of the current knowledge regarding the role of the biliary and intestinal microbiome in biliary inflammatory diseases. Results: Previously, it was suggested that the healthy biliary system is a sterile organ, while acute cholangitis and cholecystitis may occur from ascending infections. Although non-inflammatory biliary colonization by certain bacteria such as Salmonella spp. has been already recognized since several decades, human and animal studies indicated only very recently that the gallbladder harbors a complex microbiota also under non-pathologic conditions. Novel findings suggested that - similar to the situation in the intestine - the biliary mucosa features a chemical, mechanical, and immunological barrier, ensuring immunological tolerance against commensals. However, microbial triggers might influence acute and chronic inflammatory disease of the biliary system and the whole liver. Conclusion: Although yet undefined, dysbiosis of the biliary or intestinal microbiota rather than a single microorganism may influence disease progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据